Market Movers (8-K)
See all →NASDAQ
IOSP
Innospec INCInnospec Inc. announced robust second quarter 2026 financial results, with total revenues increasing 12% year-over-year to $491.4 million, driven by strong contributions from all business segments.
NASDAQ
IOSP
Innospec INCInnospec Inc. has expanded its Board of Directors to eight members with the appointment of Shelley Bausch, effective July 1, 2026.
NASDAQ
IOSP
Innospec INCInnospec Inc. announced the results of its 2026 Annual Meeting of Stockholders, with all Class I directors re-elected and advisory approval of executive compensation.
NASDAQ
IOSP
Innospec INCInnospec Inc. announced its first quarter 2026 financial results, reporting total revenues of $453.2 million and a 10 percent increase in its semi-annual dividend.
Worse than expected
Delay expected
NASDAQ
IOSP
Innospec INCInnospec Inc. reported mixed third-quarter 2025 financial results with strong Fuel Specialties performance offsetting declines in other segments, alongside a 10% dividend increase.
Worse than expected
NASDAQ
IOSP
Innospec INCInnospec Inc. reported a decline in second-quarter net income and adjusted EBITDA despite a slight revenue increase, driven by strong Fuel Specialties performance offsetting weaker results in Performance Chemicals and Oilfield Services.
Worse than expected
Quarterly Earnings (10-Q)
See all →NASDAQ
IOSP
Innospec INCInnospec Inc. announced a 12% increase in net sales for the second quarter of 2026, driven by strong performance across its Fuel Specialties and Oilfield Services segments, alongside a notable improvement in overall operating income.
NASDAQ
IOSP
Innospec INCInnospec reports Q1 2026 net income of $30.4 million on $453.2 million in revenue, reflecting mixed segment performance and increased operating costs.
Worse than expected
NASDAQ
IOSP
Innospec INCInnospec Inc. reports a significant decline in Q3 2025 net income and operating cash flow, primarily due to substantial asset impairments and underperformance in its Oilfield Services and Performance Chemicals segments.
Worse than expected
NASDAQ
IOSP
Innospec INCInnospec Inc. reported a significant decline in net income and earnings per share for the second quarter and first half of 2025, despite a slight increase in Q2 net sales, primarily due to weaker performance in Oilfield Services and Performance Chemicals.
Capital raise
Worse than expected
NASDAQ
IOSP
Innospec INCInnospec Inc. reports a decrease in net sales for Q1 2025, primarily driven by a significant downturn in its Oilfield Services segment, despite growth in Performance Chemicals.
Worse than expected
NASDAQ
IOSP
Innospec INCInnospec Inc. saw a mixed third quarter with strong performance in its Performance Chemicals segment offsetting a significant decline in Oilfield Services, while Fuel Specialties remained relatively stable.
Worse than expected
Annual Reports (10-K)
NASDAQ
IOSP
Innospec INCInnospec Inc. announces its 2024 financial results, showcasing growth in Performance Chemicals and Fuel Specialties segments offsetting a decline in Oilfield Services.
Worse than expected
NASDAQ
IOSP
Innospec INCInnospec Inc.'s 2023 annual report reveals a year of mixed performance, with growth in Oilfield Services offsetting declines in Performance Chemicals, alongside strategic acquisitions and a focus on long-term growth.
Worse than expected
Insider Trading (Form 4)
See all →NASDAQ
IOSP
Innospec INCCorbin Barnes, SVP, Corporate Dev and IR of Innospec Inc., received 2,642 shares of common stock on October 1, 2026.
NASDAQ
IOSP
Innospec INCHardy Louis Griffin Iii, SVP, HUMAN RESOURCES of Innospec Inc., received 2,685 shares of common stock on October 1, 2026.
NASDAQ
IOSP
Innospec INCIan Cleminson, EVP & CFO of Innospec Inc., received 4,792 shares of common stock on October 1, 2026.
NASDAQ
IOSP
Innospec INCIan Malcolm Mcrobbie, Senior VP R&T of Innospec Inc., received 3,164 shares of common stock on October 1, 2026.
NASDAQ
IOSP
Innospec INCDavid B. Jones, SVP, GC & CCO of Innospec Inc., received 3,188 shares of common stock on October 1, 2026.
NASDAQ
IOSP
Innospec INCPatrick Williams, PRESIDENT & CEO of Innospec Inc., received 22,203 shares of common stock on October 1, 2026.
Proxy Statements (Def-14A)
NASDAQ
IOSP
Innospec INCInnospec Inc. announces its 2026 Annual Meeting of Stockholders to address director elections, executive compensation, and auditor ratification, emphasizing strong corporate governance and sustainability.
Worse than expected
Delay expected
NASDAQ
IOSP
Innospec INCInnospec Inc. will hold its annual stockholder meeting on May 9, 2025, and has made proxy materials available online.
NASDAQ
IOSP
Innospec INCInnospec Inc. has released its proxy statement for the 2025 Annual Meeting of Stockholders, outlining key proposals, corporate governance practices, and executive compensation details.
NASDAQ
IOSP
Innospec INCInnospec Inc. will hold its annual stockholder meeting on May 10, 2024, to vote on the election of directors, executive compensation, and the ratification of the independent registered accounting firm.
NASDAQ
IOSP
Innospec INCInnospec Inc. releases its proxy statement outlining proposals for the 2024 Annual Meeting of Stockholders, including the election of directors and executive compensation.
Schedule 13G - Passive Investments
See all →NASDAQ
IOSP
Innospec INCAllspring Global Investments Holdings, LLC has increased its beneficial ownership of Innospec Inc. common stock to 4.7%, holding over 1.16 million shares.
NASDAQ
IOSP
Innospec INCAllspring Global Investments Holdings, LLC has updated its beneficial ownership filing for Innospec Inc., reporting a 4.7% stake.
NASDAQ
IOSP
Innospec INCAllspring Global Investments Holdings, LLC has increased its beneficial ownership of Innospec Inc. common stock to 7.7%, holding 1,892,471 shares.
NASDAQ
IOSP
Innospec INCVanguard Capital Management reports beneficial ownership of 1,300,194 shares, representing 5.22% of Innospec Inc.'s common stock as of March 31, 2026.
NASDAQ
IOSP
Innospec INCVanguard Portfolio Management has reported a beneficial ownership of 7.51% in Innospec Inc. common stock as of March 31, 2026.
NASDAQ
IOSP
Innospec INCThe Vanguard Group reports 0% beneficial ownership in Innospec Inc. following an internal realignment that disaggregated reporting responsibilities.